Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 randomized double-blind placebo-controlled multicenter study of ZY-B007 for insomnia disorder with anxiety symptoms
CTR20254322Phase 2Active
- Sponsor
- Shanxi Provincial Hospital of Traditional Chinese Medicine
- Start
- Dec 2025
- Countries
- 1
01
Overview
A Phase 2 trial of Chaiqin Ningshen granules in Insomnia, sponsored by Shanxi Provincial Hospital of Traditional Chinese Medicine. Started Dec 2025; status: active.
02
Drugs
Chaiqin Ningshen granules
03
Conditions
Insomnia
Beyond the preview
Go deeper on CTR20254322.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20254322.